FSAD - Women’s Health Study

This study is currently closed to enrollment.

A Phase 2b, Multi-Center, Multiple-Dose, Double-Blind, Placebo-Controlled Study To Evaluate the Efficacy And Safety Of Sildenafil Cream, 3.6% In Premenopausal Patients With Female Sexual Arousal Disorder (FSAD)

woman in bed with covers


AGE: Premenopausal women, 21 +
GENDER: Female
TYPE: Interventional Treatment Study
CONDITION: Female Sexual Arousal Disorder
DEPARTMENT: Obstetrics & Gynecology
LOCATION: UH Cleveland Medical Center

Study Purpose

The purpose of this study is to find out if the investigational drug, topical Sildenafil Cream, 3.6%, increases genital arousal in women during sexual activity.